NY S01523 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 12 2023 - 25% progression
Action: 2024-01-03 - REFERRED TO HEALTH
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requires any sponsor of a clinical trial in this state, including but not limited to, a pharmaceutical drug manufacturer, pharmaceutical drug wholesaler, academic medical center, voluntary group, federal agency or health care provider, that applies for a state grant to conduct such clinical trial, to conspicuously post certain information about such clinical trial on the department's website.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires any sponsor of a clinical trial in this state, including but not limited to, a pharmaceutical drug manufacturer, pharmaceutical drug wholesaler, academic medical center, voluntary group, federal agency or health care provider, that applies for a state grant to conduct such clinical trial, to conspicuously post certain information about such clinical trial on the department's website.

Sponsors


History

DateChamberAction
2024-01-03SenateREFERRED TO HEALTH
2023-01-12SenateREFERRED TO HEALTH

Same As/Similar To

A08197 (Same As) 2024-01-03 - referred to health

New York State Sources


Bill Comments

feedback